Pulmonary hypertension (PH) is a progressive cardiopulmonary disease characterized by pulmonary vascular remodeling, increased pulmonary vascular resistance, and eventual right ventricular failure 1,2 .Key features include endothelial dysfunction, smooth muscle cell (SMC) phenotypic switching, fibrosis, inflammation, thrombosis, and immune remodeling, although their relative contributions differ across PH subtypes and models.As single-cell RNA sequencing (scRNA-seq) datasets continue to expand, a major challenge is no longer data generation but consistent interpretation of disease-associated cell states across studies, species, and tissue sources.